1. New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
   Heng Li et al, 2017, Arthritis Research & Therapy CrossRef
2. Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma
   David J. Voce et al, 2019, Cancer Research CrossRef
3. Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer
   Manuela La Montagna et al, 2021, Cancer Gene Therapy CrossRef
4. MALAT1–miR663a negative feedback loop in colon cancer cell functions through direct miRNA–lncRNA binding
   Wei Tian et al, 2018, Cell Death & Disease CrossRef
5. Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications
   A. Quintanal-Villalonga et al, 2016, Disease Markers CrossRef
6. Genome-wide identification and characterization of long non-coding RNAs involved in acquired resistance to gefitinib in non-small-cell lung cancer
   Jingjing Shi et al, 2020, Computational Biology and Chemistry CrossRef
7. Long Non-coding RNAs and Cancer Cells’ Drug Resistance: An Unexpected Connection
   Perla Pucci et al, 2020, The Chemical Biology of Long Noncoding RNAs CrossRef
8. Co-Expression Network Analysis Unveiled lncRNA-mRNA Links Correlated to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance and/or Intermediate Epithelial-to-Mesenchymal Transition Phenotypes in a Human Non-Small Cell Lung Cancer Cellular Model System
   Valentina Fustaino et al, 2024, International Journal of Molecular Sciences CrossRef
9. The functional role of long noncoding RNA in resistance to anticancer treatment
   Yidi Qu et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
10. Long non-coding RNAs in anti-cancer drug resistance
    Qin-nan Chen et al, 2017, Oncotarget CrossRef
11. Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells
    Xin Tian et al, 2017, Oncology Reports CrossRef
12. Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
    null Santoni-Rugiu et al, 2019, Cancers CrossRef
13. An in vitro and in vivo study of the role of long non‐coding RNA‐HOST2 in the proliferation, migration, and invasion of human glioma cells
    Qi Wang et al, 2019, IUBMB Life CrossRef
14. Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response
    Abril Marcela Herrera-Solorio et al, 2017, Clinical Epigenetics CrossRef
15. Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini Review
    Ruizheng Sun et al, 2019, Frontiers in Pharmacology CrossRef
16. Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy
    Ling Li et al, 2020, Frontiers in Oncology CrossRef
17. Advances in long non-coding RNA regulating drug resistance of cancer
    Zhang Ying et al, 2023, Gene CrossRef
18. Knockdown of lncRNA BLACAT1 reverses the resistance of afatinib to non-small cell lung cancer via modulating STAT3 signalling
    Degui Shu et al, 2020, Journal of Drug Targeting CrossRef